The Scientist is bringing a panel of experts together to discuss advances in our understanding of the tumor microenvironment and how this knowledge is being harnessed to develop targeted therapies.

To explore the pros and cons of using iNPCs as a model for neuronal function and dysfunction, The Scientist is bringing together a panel of experts to share their experience with iNPCs and their forecast for iNPC disease modelling for human disease.

The Scientist brings together a panel of experts to discuss strategies for detecting and quantitatively analyzing mutations in cfDNA and ctDNA and the application of this information to profile disease progression and treatment.

In this webinar, we will discuss the technical and methodological requirements for ELISpot assays, important quality control measures, essential assay qualifications, and data interpretation.

The Scientist has assembled a panel of experts to discuss the importance of epigenetic profiling in cancer research, and to explore how this knowledge can be applied to develop targeted therapies.  

The Scientist brings together a panel of experts to discuss emerging technologies for disease modeling in regenerative medicine and stem cell therapy.

The Scientist brings together a panel of experts to share their perspectives on genome-wide functional screening and applications in drug development.

The Scientist brings together a panel of experts to discuss strategies and workflows for screening and optimizing cell lines for bioproduction. 

The Scientist brings together a panel of experts to discuss the function of exosomes in cell-to-cell communication during tumor progression and metastasis.